RECI Logo
Company Profile
Back to Index
Public Evidence Profile

Pfizer Inc.

CountryUnited States
Index EditionRECI Global Index 2026 — V1
Updated3 April 2026
StatusPublished
RECI Score
82.9
Gold
Executive Summary

Pfizer Inc. receives a Gold tier designation with a score of 83.2, reflecting solid sustainability governance within the US pharmaceutical sector. Governance Chassis reaches Level 5, indicating mature sustainability oversight structures. Data Infrastructure at Level 4 and Assurance Depth capped at Level 4 constrain the overall assessment.

Technical assessment based on primary disclosures

Primary Data Source

Public Disclosure
Pfizer Inc. Sustainability Report 2024; CDP Climate Change Response 2024; Pfizer Inc. Annual Report / Integrated Report 2024

Assurance Verification

Limited Assurance (EY)
Source: Independent review of publicly available sustainability disclosures

Benchmarking Confidence

High-Medium Confidence
RECI Technical Methodology v2.4

Pillar Performance

Top:P1 Governance Chassis
Gap:P2 Data Infrastructure

Assessment

Pillar Performance

Pillar 1
Optimised5

Governance Chassis

L1L2L3L4L5
Pillar 2
Integrated4

Data Infrastructure

L1L2L3L4L5
Pillar 3
Integrated4

Financial Controls

L1L2L3L4L5
Pillar 4
Integrated4

Operational Linkage

L1L2L3L4L5
Pillar 5
Integrated4

Risk Radar

L1L2L3L4L5
Pillar 6
Integrated4

Assurance Depth

L1L2L3L4L5
Pillar 7
Integrated4

Transparency & Disclosure

L1L2L3L4L5

Index Disclaimer

RECI public scores are benchmark indicators derived from our interpretation of publicly available evidence at the time of review. They are not credit ratings, ESG ratings, certifications, or assurance statements. Scores reflect the four-stage governance process: AI analyst draft, senior ESG practitioner review, final record approval, and management calibration.